🏥 Health
1d ago
First Major Trial Win for Contemporary DOACs in Lower-Risk Afib
Source ↗
👁 0
💬 0
(MedPage Today) -- Emerging randomized data favored oral anticoagulation for lower-risk patients with atrial fibrillation (Afib), researchers found.
Among patients with Afib and one thromboembolic risk factor in the SINGLE-AF trial, direct oral...
Among patients with Afib and one thromboembolic risk factor in the SINGLE-AF trial, direct oral...
Comments (0)